ARKK vs STXS
ARK Innovation ETF (ARKK) versus Stereotaxis Inc (STXS) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
Stereotaxis Inc (STXS) is a medical instruments & supplies company listed on AMEX.
ARKK does not have a complete income-statement cache yet.
Latest reported STXS revenue for 2026-06-30 was $14.0M. Net income was -$10.3M. STXS currently screens at market cap $174.0M.
ARKK currently screens at market cap $0. STXS currently screens at market cap $174.0M.
Not investment advice. Open the ARKK and STXS stock pages for the full models.
Not investment advice.